Journal Report

BIOpreparations. Prevention, Diagnosis, Treatment

Download PDF
Journal Information
Journal Title
BIOpreparations. Prevention, Diagnosis, Treatment
Publisher
National Electronic-Information Consortium (NEICON)
ISSN
2221-996X
E-ISSN
2619-1156
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓
2025
2024
2023
2021/2022
2020
2019
2018
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Sublingual dosage form of an antiviral medicinal product based on double-stranded RNA and recombinant interferon alpha-2b: A physicochemical and biological study
O. S. Ivanova, E. S. Bashkina, S. V. Usova et al.
2026-10-19
DOI: 10.30895/2221-996x-2026-707
Structural and functional stability of lyophilized nonencapsulated mRNA synthesized in vitro during long-term storage
S. V. Sharabrin, S. I. Krasnikova, D. N. Kisakov et al.
2026-10-5 Vol. 26 Issue 3 Pages 299-310
DOI: 10.30895/2221-996x-2026-26-3-299-310
mRNA vaccines for the prevention of infectious diseases: A review of international experience in evaluating efficacy and safety based on clinical trial results
A. Yu. Butirskiy, A. S. Korovkin, D. V. Gorenkov et al.
2026-10-5 Vol. 26 Issue 3 Pages 311-323
DOI: 10.30895/2221-996x-2026-26-3-311-323
Oligonucleotide-based medicinal products: A review of current regulatory requirements for preclinical studies
G. N. Engalycheva, R. D. Syubaev, A. A. Berchatova et al.
2026-10-5 Vol. 26 Issue 3 Pages 262-275
DOI: 10.30895/2221-996x-2026-26-3-262-275
Criteria for the application of the platform approach for mRNA vaccines and gene therapy products in regulatory practice
N. S. Pokrovsky, E. V. Melnikova, V. A. Merkulov
2026-10-5 Vol. 26 Issue 3 Pages 247-261
DOI: 10.30895/2221-996x-2026-26-3-247-261
A two-component mRNA vaccine combining B-cell and T-cell immunogens of SARS-CoV-2 induces humoral and cellular immune responses in mice
M. B. Borgoyakova, A. P. Rudometov, S. V. Sharabrin et al.
2026-10-5 Vol. 26 Issue 3 Pages 287-298
DOI: 10.30895/2221-996x-2026-26-3-287-298
Genetic characterization of production strains of measles, rubella, and mumps viruses by high-throughput sequencing
A. I. Zheltukhina, A. B. Komissarov, A. V. Fadeev et al.
2026-10-5 Vol. 26 Issue 3 Pages 336-348
DOI: 10.30895/2221-996x-2026-750
Administration of the mRNA-H5 vaccine to ferrets via jet injection provides protective immunity against the H5N1 influenza virus
V. R. Litvinova, A. S. Gudymo, V. A. Yakovlev et al.
2026-10-5 Vol. 26 Issue 3 Pages 276-286
DOI: 10.30895/2221-996x-2026-26-3-276-286
Vaccines for the prevention of hantavirus fevers: An overview of results and development prospects
R. D. Teodorovich, T. K. Dzagurova, S. S. Kurashova et al.
2026-10-5 Vol. 26 Issue 3 Pages 324-335
DOI: 10.30895/2221-996x-2026-26-3-324-335
Inactivation of Mycoplasma gallisepticum and Mycoplasma synoviae during influenza vaccine production
N. N. Savina, M. Sh. Aliev, A. I. Reutskiy et al.
2026-10-5 Vol. 26 Issue 3 Pages 349-358
DOI: 10.30895/2221-996x-2026-729
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 25, 2026 19:56